Arcturus Therapeutics's total assets for Q4 2025 were $271.15M, a decrease of -3.97% from the previous quarter. ARCT total liabilities were $57.16M for the fiscal quarter, a -1.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.